ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Stromal Tumor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-3H3477
Home | Market Reports | Health| Health Conditions| Cancer
Global Gastrointestinal Stromal Tumor Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastrointestinal Stromal Tumor Market Research Report 2025

Code: QYRE-Auto-3H3477
Report
September 2025
Pages:66
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Sun Pharmaceutical
Pfizer Inc
Bayer Aktiengesellschaft
Natco Pharma

Gastrointestinal Stromal Tumor Market

The global market for Gastrointestinal Stromal Tumor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor.
The Gastrointestinal Stromal Tumor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Stromal Tumor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastrointestinal Stromal Tumor Market Report

Report Metric Details
Report Name Gastrointestinal Stromal Tumor Market
Segment by Type
  • Stomach
  • Small Intestine
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Specialized Cancer Treatment Centers
  • Other End Users
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, ​​Sun Pharmaceutical, Pfizer, Bayer Aktiengesellschaft, NATCO Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastrointestinal Stromal Tumor Market report?

Ans: The main players in the Gastrointestinal Stromal Tumor Market are Novartis, ​​Sun Pharmaceutical, Pfizer, Bayer Aktiengesellschaft, NATCO Pharma

What are the Application segmentation covered in the Gastrointestinal Stromal Tumor Market report?

Ans: The Applications covered in the Gastrointestinal Stromal Tumor Market report are Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End Users

What are the Type segmentation covered in the Gastrointestinal Stromal Tumor Market report?

Ans: The Types covered in the Gastrointestinal Stromal Tumor Market report are Stomach, Small Intestine, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2020-2031)
2.2 Global Gastrointestinal Stromal Tumor Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Stromal Tumor Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Stromal Tumor Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Stromal Tumor Revenue
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2024
3.5 Global Key Players of Gastrointestinal Stromal Tumor Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2020-2031)
6.2 North America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Stromal Tumor Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2020-2031)
7.2 Europe Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2020-2031)
9.2 Latin America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 ​​Sun Pharmaceutical
11.2.1 ​​Sun Pharmaceutical Company Details
11.2.2 ​​Sun Pharmaceutical Business Overview
11.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2020-2025)
11.2.5 ​​Sun Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Details
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2020-2025)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Details
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2020-2025)
11.5.5 NATCO Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Sun Pharmaceutical
Pfizer Inc
Bayer Aktiengesellschaft
Natco Pharma
List of Tables
 Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stomach
 Table 3. Key Players of Small Intestine
 Table 4. Key Players of Others
 Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gastrointestinal Stromal Tumor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Gastrointestinal Stromal Tumor Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Gastrointestinal Stromal Tumor Market Share by Region (2020-2025)
 Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Gastrointestinal Stromal Tumor Market Share by Region (2026-2031)
 Table 11. Gastrointestinal Stromal Tumor Market Trends
 Table 12. Gastrointestinal Stromal Tumor Market Drivers
 Table 13. Gastrointestinal Stromal Tumor Market Challenges
 Table 14. Gastrointestinal Stromal Tumor Market Restraints
 Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Gastrointestinal Stromal Tumor Market Share by Players (2020-2025)
 Table 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2024)
 Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Gastrointestinal Stromal Tumor, Headquarters and Area Served
 Table 21. Global Key Players of Gastrointestinal Stromal Tumor, Product and Application
 Table 22. Global Key Players of Gastrointestinal Stromal Tumor, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2020-2025)
 Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2026-2031)
 Table 28. Global Gastrointestinal Stromal Tumor Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2020-2025)
 Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2026-2031)
 Table 32. North America Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Gastrointestinal Stromal Tumor Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Gastrointestinal Stromal Tumor Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Gastrointestinal Stromal Tumor Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Gastrointestinal Stromal Tumor Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Gastrointestinal Stromal Tumor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Gastrointestinal Stromal Tumor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Novartis Company Details
 Table 48. Novartis Business Overview
 Table 49. Novartis Gastrointestinal Stromal Tumor Product
 Table 50. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2020-2025) & (US$ Million)
 Table 51. Novartis Recent Development
 Table 52. ​​Sun Pharmaceutical Company Details
 Table 53. ​​Sun Pharmaceutical Business Overview
 Table 54. ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Product
 Table 55. ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2020-2025) & (US$ Million)
 Table 56. ​​Sun Pharmaceutical Recent Development
 Table 57. Pfizer Company Details
 Table 58. Pfizer Business Overview
 Table 59. Pfizer Gastrointestinal Stromal Tumor Product
 Table 60. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2020-2025) & (US$ Million)
 Table 61. Pfizer Recent Development
 Table 62. Bayer Aktiengesellschaft Company Details
 Table 63. Bayer Aktiengesellschaft Business Overview
 Table 64. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product
 Table 65. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2020-2025) & (US$ Million)
 Table 66. Bayer Aktiengesellschaft Recent Development
 Table 67. NATCO Pharma Company Details
 Table 68. NATCO Pharma Business Overview
 Table 69. NATCO Pharma Gastrointestinal Stromal Tumor Product
 Table 70. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2020-2025) & (US$ Million)
 Table 71. NATCO Pharma Recent Development
 Table 72. Research Programs/Design for This Report
 Table 73. Key Data Information from Secondary Sources
 Table 74. Key Data Information from Primary Sources
 Table 75. Authors List of This Report


List of Figures
 Figure 1. Gastrointestinal Stromal Tumor Picture
 Figure 2. Global Gastrointestinal Stromal Tumor Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastrointestinal Stromal Tumor Market Share by Type: 2024 VS 2031
 Figure 4. Stomach Features
 Figure 5. Small Intestine Features
 Figure 6. Others Features
 Figure 7. Global Gastrointestinal Stromal Tumor Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gastrointestinal Stromal Tumor Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Specialized Cancer Treatment Centers Case Studies
 Figure 12. Other End Users Case Studies
 Figure 13. Gastrointestinal Stromal Tumor Report Years Considered
 Figure 14. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Gastrointestinal Stromal Tumor Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Gastrointestinal Stromal Tumor Market Share by Region: 2024 VS 2031
 Figure 17. Global Gastrointestinal Stromal Tumor Market Share by Players in 2024
 Figure 18. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2024
 Figure 20. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Gastrointestinal Stromal Tumor Market Share by Country (2020-2031)
 Figure 22. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Gastrointestinal Stromal Tumor Market Share by Country (2020-2031)
 Figure 26. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Region (2020-2031)
 Figure 34. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Gastrointestinal Stromal Tumor Market Share by Country (2020-2031)
 Figure 42. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Country (2020-2031)
 Figure 46. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Gastrointestinal Stromal Tumor Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2020-2025)
 Figure 50. ​​Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2020-2025)
 Figure 52. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2020-2025)
 Figure 53. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions